首页|Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin

Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Ovarian cancer is the most lethal and aggressive gynecological cancer with a high recurrencerate and is often diagnosed late.In ovarian cancer,multiple metabolic enzymes of lipid metabolism are abnormally expressed,resulting in metabolism disorder.As a characteristic pathway in polyunsaturated fatty acid(PUFA)metabolism,arachidonic acid(AA)metabolism is disturbed in ovarian cancer.Therefore,we established a 10-gene signature model to evaluate the prognostic risk of PUFA-related genes.This 10-gene signature has strong robustness and can play a stable predictive role in datasets of various platforms(TCGA,ICGC,and GSE17260).The high association between the risk subgroups and clinical characteristics indicated a good performance of the model.Our data further indicated that the high expression of LTA4H was positively correlated with poor prognosis in ovarian cancer.Deficiency of LTA4H enhanced sensitivity to Cisplatin and modified the characteristics of immune cell infiltration in ovarian cancer.Additionally,our results indicate that CCL5 was involved in the aberrant metabolism of the AA/LTA4H axis,which contributes to the reduction of tumor-infiltrating CD8+T cells and immune escape in ovarian cancer.These findings provide new insights into the prognosis and potential target of LTA4H/CCL5 in treating ovarian cancer.

ovarian cancerpolyunsaturated fatty acidsprognostic risk modelLTA4Htumor immunityCCL5

Zhengyang Guo、Jiaqi Huang、Xiao Huo、Chen Huang、Xiaotong Yu、Yan Sun、Yanfang Li、Tianhui He、Hongyan Guo、Jianling Yang、Lixiang Xue

展开 >

Cancer Center of Peking University Third Hospital,Beijing 100191,China

Center of Basic Medical Research,Institute of Medical Innovation and Research,Peking University Third Hospital,Beijing 100191,China

Peking University Third Hospital Cancer Center,Department of Radiation Oncology,Peking University Third Hospital,Beijing 100191,China

Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing 100191,China

展开 >

General Program of National Natural Science Foundation of ChinaGeneral Program of National Natural Science Foundation of ChinaGeneral Program of National Natural Science Foundation of ChinaGeneral Program of Natural Science Foundation of BeijingNational Key Research and Development Program of ChinaYouth Program of National Natural Science Foundation of ChinaYouth Program of National Natural Science Foundation of ChinaPeking University Third Hospital Clinical Key Project

82272745820728708197296672022242022YFA11040018220310282303801BYSY2022069

2024

10.1007/s11427-023-2444-5

中国科学:生命科学(英文版)
中国科学院

中国科学:生命科学(英文版)

CSTPCD
影响因子：0.806
ISSN：1674-7305
年,卷(期)：2024.67(6)
  • 1